drugset / Trial / NCT04486326
Crofelemer for Functional Diarrhea
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objectives of this study are to evaluate the clinical response of patients with diarrhea to crofelemer relative to placebo and evaluate the overall safety and tolerability of crofelemer in the treatment of diarrhea.
Timeline
- Start
- 2020-08-20
- Primary completion
- 2022-09-23
- Completion
- 2022-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Crofelemer | Small molecule | 125 mg | — |